CAF-derived exosomal miR-20a enhanced chemoresistance in non-small-cell lung cancer (NSCLC) [109] and targeted the Wnt/β-catenin signaling pathway in HCC cells, which led to the suppression of LIMA1 and tumor progression [109]. The gene discussed is LIMA1; the disease is non-small cell lung carcinoma.